Trade
Take Solutions share price
High risk
You have to be logged in to add this to Watchlist.- ₹10.85(-4.99%)July 8, 2025 15:54:39 PM IST
- NSE
- BSE
- Vol : 307.61K (NSE + BSE)Last 20 day avg : 84.91 K
Take Solutions is trading -4.99% lower at Rs 10.85 as compared to its last closing price. Take Solutions has been trading in the price range of 11.98 & 10.85. Take Solutions has given -29.02% in this year & 27.31% in the last 5 days. The company posted a net profit of -4.88 Crores in its last quarter.Listed peers of Take Solutions include Auro Laboratories (-0.57%), Bdh Industries (1.59%), Take Solutions (-4.99%).The Mutual Fund holding in Take Solutions was at -% in . The MF holding has - from the last quarter. The FII holding in Take Solutions was at 0.02% in 31 Mar 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 08, 2025, 09:16 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values7.75The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values4.25Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.21Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Take Solutions News
Take Solutions Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is not profitable
The company has reduced its March quarter loss by 95.59% from Rs 110.61 crore to Rs 4.88 crore, year-on-year- Earnings are insufficient to cover the interest expenses on outstanding debt
Take Solutions Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 10.87
- R2
- 12.78
- R3
- 14.13
Pivot9.52
- S1
- 7.61
- S2
- 6.26
- S3
- 4.35
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Take Solutions Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Auro Laboratories | Neutral | 253.55 | -0.57 | 154.98 | 86.14 | 3.69 | - | 77.00 |
| Bdh Industries | Bearish | 262.40 | 1.59 | 151.04 | 16.69 | 2.25 | 1.67 | - |
| Take Solutions | Moderately Bullish | 10.85 | -4.99 | 160.51 | 205.63 | 7.39 | - | - |
| Parmax Pharma | Neutral | 42.00 | 8.95 | 15.72 | - | - | - | |
| Smruthi Organics | Moderately Bullish | 125.05 | -2.11 | 142.92 | 40.70 | 2.02 | 1.18 | 11.35 |
Take Solutions Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Take Solutions is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 53.41%
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
Take Solutions Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-07-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2025-01-22 | Quarterly Results |
| 2024-05-30 | Audited Results |
About the company Take Solutions
- IndustryBiotechnology & Drugs
- ISININE142I01023
- BSE Code532890
- NSE CodeTAKE
Take Solutions Limited is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.
Take Solutions Share Price FAQs
Take Solutions is trading at 10.85 as on Tue Jul 08 2025 10:24:39. This is -4.99% lower as compared to its previous closing price of 11.42.
The market capitalization of Take Solutions is 160.51 Cr as on Tue Jul 08 2025 10:24:39.
The 52 wk high for Take Solutions is 23.68 whereas the 52 wk low is 6.70
Take Solutions can be analyzed on the following key metrics -
- TTM P/E: 146.94
- Sector P/E: -
- Dividend Yield: 0.00%
- D/E ratio: 0.00
Take Solutions reported a net profit of 37.47 Cr in 2025.
Quick Links